The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers

Glenn J. Hanna*, Ji Eun Bae, Jochen H. Lorch, Robert I. Haddad, Vickie Y. Jo, Jonathan D. Schoenfeld, Danielle N. Margalit, Roy B. Tishler, Laura A. Goguen, Donald J. Annino, Nicole G. Chau

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science